본문 바로가기
KERD
논문KCI 등재

당뇨망막병증 최신 지견

New Modalities for the Diagnosis and Treatment of Diabetic Retinopathy

송수정|계효정
대한내과학회 (The Korean Association Of Internal Medicine)|2015.09|대한내과학회지 (The Korean Journal of Medicine)|제89권 제3호|pp. 271-276|DOI http://dx.doi.org/10.3904/kjm.2015.89.3.271

1

조회

0

다운로드

5

인용

0

참고문헌

키워드

역학EpidemiologyTreatment당뇨망막병증Diabetic retinopathy진단치료Diagnosis
주제분류내과학

초록

당뇨망막병증은 당뇨병성 만성합병증 중 하나로 전 세계적으로 중요 실명 원인 중 하나이다[1,2]. 최근 당뇨망막병증의 진단 분야에서는 무산동 광각 안저 촬영(nonmydriatic ultra wide field fundus photography)과 스펙트럼 영역 빛간섭단층촬영(spectral domain optical coherence tomography)이 보편화되고, 치료에서 여러 가지 항혈관내피세포 성장인자들(vascular endothelial growth factor)의 유리체강 내 주사가 광범위하게 사용되고 있다. 또한 역학에서도 제5기 국민건강영양역학조사결과가 발표되면서 당뇨망막병증의 역학에 대한 최신 결과들이 발표되었다[3]. 이에 당뇨망막병증의 역학, 진단, 그리고 치료에 대한 최신 자료들을 소개하고자 한다.

Abstract

Over the past decade, significant advances have been made in both the diagnosis and treatment of diabetic retinopathy. Ultrawide field fundus photography and spectral domain optical coherence tomography have allowed more accurate, convenient, and early diagnosis of diabetic retinopathy. Numerous randomized clinical trials have demonstrated the effectiveness of anti-vascular endothelial growth factor agents for the treatment of diabetic retinopathy, although more work is necessary in terms of long-term clinical outcomes and socioeconomic costs associated with these treatments.

참고문헌 (42)

  1. Cheung N, "Diabetic retinopathy", Lancet, 376, pp.124~136 (2010)
  2. Yau JW, "Meta-Analysis for Eye Disease (META-EYE) Study Group. Global prevalence and major risk factors of diabetic retinopathy", Diabetes Care, 35, pp.556~564 (2012)
  3. Yang JY, "Prevalence and factors associated with diabetic retinopathy in a Korean adult population:the 2008-2009 Korea National Health and Nutrition Examination Survey", Diabetes Res Clin Pract, 102, pp.218~224 (2013)
  4. Hovind P, "Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes", Diabetes Care, 26, pp.1258~1264 (2003)
  5. Klein R, "Is the prevalence of visual impairment rising or falling in the people with diabetes mellitus? It depends on who you study", JAMA Ophthalmol, 131, pp.948~950 (2013)
  6. Klein R, "The Wisconsin Epidemiologic Study of Diabetic Retinopathy:XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes", Ophthalmology, 115, pp.1859~1868 (2008)
  7. Nordwall M, "Linkoping Diabetes Complications Study. Declining incidence of severe retinopathy and persisting decrease of nephropathy in an unselected population of type 1 diabetes-the Linkoping Diabetes Complications Study", Diabetologia, 47, pp.1266~1272 (2004)
  8. Klein R, "The Wisconsin Epidemiologic Study of Diabetic Retinopathy XXIII: the twenty-five-year incidence of macular edema in persons with type 1 diabetes", Ophthalmology, 116, pp.497~503 (2009)
  9. Klein R, "Are individuals with diabetes seeing better?:a long-term epidemiological perspective", Diabetes, 59, pp.1853~1860 (2010)
  10. Park CY, "Prevalence of and risk factors for diabetic retinopathy in Koreans with type II diabetes:baseline characteristics of Seoul Metropolitan City-Diabetes Prevention Program (SMC-DPP) participants", Br J Ophthalmol, 96, pp.151~155 (2012)
  11. 김윤전, "Development and Progression of Diabetic Retinopathy and Associated Risk Factors in Korean Patients with Type 2 Diabetes: The Experience of a Tertiary Center", Journal of Korean Medical Science, 12(12), pp.1699~1705 (2014), 대한의학회
  12. Huang YC, "Genome-wide association study of diabetic retinopathy in a Taiwanese population", Ophthalmology, 118, pp.642~648 (2011)
  13. Sheu WH, "Genome-wide association study in a Chinese population with diabetic retinopathy", Hum Mol Genet, 22, pp.3165~3173 (2013)
  14. Dirani M, "Are obesity and anthropometry risk factors for diabetic retinopathy? The diabetes management project", Invest Ophthalmol Vis Sci, 52, pp.4416~4421 (2011)
  15. Klein R, "Is obesity related to microvascular and macrovascular complications in diabetes? The Wisconsin Epidemiologic Study of Diabetic Retinopathy", Arch Intern Med, 157, pp.650~656 (1997)
  16. Tanaka S, "Japan Diabetes Complications Study Group. Fruit intake and incident diabetic retinopathy with type 2 diabetes", Epidemiology, 24, pp.204~211 (2013)
  17. Djuric Z, "Effects of high fruit-vegetable and", or low-fat intervention on plasma micronutrient levels, 2006, pp.25, 178~187
  18. Manivannan A, "Ultra-wide-field fluorescein angiography of the ocular fundus", Am J Ophthalmol, 140, pp.525~527 (2005)
  19. Wessel MM, "Ultra-wide-field angiography improves the detection and classification of diabetic retinopathy", Retina, 32, pp.785~791 (2012)
  20. Wessel MM, "Peripheral retinal ischaemia, as evaluated by ultrawidefield fluorescein angiography, is associated with diabetic macular oedema", Br J Ophthalmol, 96, pp.694~698 (2012)
  21. Lim JI, "Inner and outer retinal thickness mapping of nonproliferative diabetic retinopathy by spectral-domain optical coherence tomography", Ophthalmic Surg Lasers Imaging Retina, 46, pp.316~320 (2015)
  22. Boynton GE, "Multimodal characterization of proliferative diabetic retinopathy reveals alterations in outer retinal function and structure", Ophthalmology, 122, pp.957~967 (2015)
  23. Bonnin S, "Correlation between ganglion cell layer thinning and poor visual function after resolution of diabetic macular edema", Invest Ophthalmol Vis Sci, 56, pp.978~982 (2015)
  24. Penn JS, "Vascular endothelial growth factor in eye disease", Prog Retin Eye Res, 27, pp.331~371 (2008)
  25. Photocoagulation for diabetic macular edema, "Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group", Arch Ophthalmol, 103, pp.1796~1806 (1985)
  26. Diabetic Retinopathy Clinical Research Network, "A randomized trial comparing intravitreal triamcinolone acetonide and focal", grid photocoagulation for diabetic macular edema, 2008, pp.115, 1447~1449
  27. Diabetic Retinopathy Clinical Research Network, "Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema", Ophthalmology, 117, pp.1064~1077.e35 (2010)
  28. Boyer DS, "Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema", Ophthalmology, 121, pp.1904~1914 (2014)
  29. Callanan DG, "Dexamethasone intravitreal implant in combination with laser photocoagulation for the treatment of diffuse diabetic macular edema", Ophthalmology, 120, pp.1843~1851 (2013)
  30. Lauer AK, "Frequency of intraocular pressure increase within days after intravitreal triamcinolone injections in the diabetic retinopathy clinical research network", Arch Ophthalmol, 129, pp.1097~1099 (2011)
  31. Diabetic Retinopathy Clinical Research Network, "Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema", N Engl J Med, 372, pp.1193~1203 (2015)
  32. Nguyen QD, "RISE and RIDE Research Group. Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE", Ophthalmology, 119, pp.789~801 (2012)
  33. Brown DM, "RIDE and RISE Research Group. Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE", Ophthalmology, 120, pp.2013~2022 (2013)
  34. Massin P, "Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): a 12-month, randomized, controlled, double-masked, multicenter phase II study", Diabetes Care, 33, pp.2399~2405 (2010)
  35. Mitchell P, "The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema", Ophthalmology, 118, pp.615~625 (2011)
  36. Michaelides M, "A prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (BOLT study)12-month data: report 2", Ophthalmology, 117, pp.1078~1086.e2 (2010)
  37. Moja L, "Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration", Cochrane Database Syst Rev, 9, pp.CD011230~ (2014)
  38. Do DV, "The DA VINCI Study: phase 2 primary results of VEGF Trap-Eye in patients with diabetic macular edema", Ophthalmology, 118, pp.1819~1826 (2011)
  39. Korobelnik JF, "Intravitreal aflibercept for diabetic macular edema", Ophthalmology, 121, pp.2247~2254 (2014)
  40. Farouk MM, "Outcomes of 25-gauge vitrectomy for proliferative diabetic retinopathy", Graefes Arch Clin Exp Ophthalmol, 249, pp.369~376 (2011)
  41. Park DH, "Comparison of clinical outcomes between 23-gauge and 20-gauge vitrectomy in patients with proliferative diabetic retinopathy", Retina, 30, pp.1662~1670 (2010)
  42. Ozone D, "Outcomes and complications of 25-gauge transconjunctival sutureless vitrectomy for proliferative diabetic retinopathy", Ophthalmologica, 226, pp.76~80 (2011)

관련 논문AI추천

당뇨망막병증 진행 정도에 따른 빛간섭단층혈관촬영술우제문, 우종은, 윤요셉대한안과학회 · 대한안과학회지2017 · 제58권 제6호경도 비증식당뇨망막병증에서 빛간섭단층혈관촬영술을 이용한 황반부 미세혈관의 초기변화김형찬, 지복준대한안과학회 · 대한안과학회지2016 · 제57권 제11호한국과 일본의 당뇨망막병증 치료에 대한 경향 비교김중엽, 박태관, 신재필, 오재령, 유승영, 이주은, 이지은, 장우혁, 조영준대한안과학회 · 대한안과학회지2016 · 제57권 제8호당뇨망막병증 검진에 있어 무산동 디지털 안저사진기의 효용성배정훈, 송수정, 이대웅대한안과학회 · 대한안과학회지2011 · 제52권 제5호혈관빛간섭단층촬영을 이용한 정상인과 당뇨망막병증 환자에서의 망막중심오목 무혈관부위 분석김인근, 이주은대한안과학회 · 대한안과학회지2017 · 제58권 제8호당뇨망막병증을 동반하지 않은 당뇨환자에서 황반부 미세혈관의 변화와 연관된 전신인자 분석김하경, 배소현, 조준희, 최상욱대한안과학회 · 대한안과학회지2017 · 제58권 제7호

이 간행물의 다른 논문 (6건)

당뇨병성 신증의 최신 지견김난희pp. 265-2701차 진료의를 위한 쇼그렌증후군곽승기pp. 291-294관상동맥 중재술을 받은 환자에서 실로스타졸 사용 후 동맥경직도의 변화고진신, 황진용, 안종화, 김계환, 강영란, 박정랑, 박용휘, 정영훈, 황석재, 조상영, 곽충환pp. 295-304비전형적인 증상의 람블편모충 감염에 의한 대장염 1예김미희, 박선호, 이진희, 이윤희, 신옥란, 조영석, 최수경pp. 312-316터너증후군 환자의 대동맥 축착증을 스텐트 삽입술로 치료한 증례 1예박치환, 박승운, 이남희, 박인성, 이한철, 유진석pp. 331-334
원문 보기